1124 W. Carson Street
24 articles with LA BioMed
Post-menopausal women on low-fat diets had materially better outcomes
Researchers at LA BioMed in Torrance, CA have been working to create a therapeutic vaccine for 2 years to fight infections caused by Candida auris.
Product developed at LA BioMed is a safe, economical, available primary therapy
New Program Creates a Triple Threat: Graduates with Clinical, Business & Research Skills
Pay Inequality Hits the Operating Room – LA BioMed Study Finds Female Docs Uncomfortable Pursuing Comparable Salaries to Men
While male and female surgeons both work equally hard saving lives in the operating room, women in general surgery project earning significantly less than men.
$5.3 million NIH grant will fund research on effective therapies for antibiotic-resistant strains
Two studies are part of broader effort to take aim at one of the world’s deadliest infections
Dr. Meyer to lead panel of thought leaders capitalizing on region’s role as influential bioscience hub
Event Bolsters Los Angeles as a National Biotech Hub
The Latest Medical Innovations in Therapeutics, Diagnostics, and Medical Devices.
Demand for organization’s first bond issue was more than twice the offering size.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
A groundbreaking study by LA BioMed researchers shows promising results for a potential vaccine for deadly drug-resistant bacteria also known as superbugs.
LA BioMed announced the launch of two new male contraceptive studies.
NIH funded research led by Dr. Rie Sakai-Bizmark has potential to save the lives of hundreds of newborn babies annually.
A researcher from LA BioMed has been awarded $688,013 in grant funding from the National Institutes of Health to improve newborn infant screening. The proposal by Rie Sakai-Bizmark, MD, PhD, MPH is entitled "Newborn Screening for Critical Congenital Heart Disease in U.S.: Assessment of implementation obstacles and application of cost-effectiveness to gauge if action needed for improved implementation."
A new 78,000 SF research building and bioscience incubator are set to open in early 2019, further securing LA BioMed's contribution to biotech leadership in Southern California
A breakthrough in oral male contraception, researchers show feasibility of "the pill" for men.
California Life Sciences Association Partners With LA BioMed And Lab Launch To Grow World-Class Life Sciences Innovation Hub In Los Angeles; Opens Los Angeles Office